Patents by Inventor Christopher James Nirschl

Christopher James Nirschl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-TIGIT antigen-binding proteins and methods of use thereof
    Patent number: 11453720
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: September 27, 2022
    Assignee: Potenza Therapeutics, Inc.
    Inventors: Nels P. Nielson, Daniel Hicklin, Cynthia Seidel-Dugan, William Winston, Heather Brodkin, Jose-Andres Salmeron-Garcia, Christopher James Nirschl, Philipp Steiner
  • ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20200095324
    Abstract: Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: March 30, 2018
    Publication date: March 26, 2020
    Inventors: Nels P. Nielson, Daniel Hicklin, Cynthia Seidel-Dugan, William Winston, Heather Brodkin, Jose-Andres Salmeron-Garcia, Christopher James Nirschl, Philipp Steiner